Given the empirical evidence in the recent decade for sleep as a potent regulator of proteostasis, we postulate the sleep-proteostasis relationship is critical in the early phase of AD: with Aβ and tau accumulation the neuronal electrophysiological signature of sleep becomes impaired, hence contributing to exacerbated proteinopathy. The gene discussed is MAPT; the disease is Alzheimer disease.